Scarica l'app Stockscreener
2.17
1.40%
0.03
Dopo l'orario di chiusura:
2.19
0.02
+0.92%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CABA Giù?
Forum
Previsione
Precedente Chiudi:
$2.14
Aprire:
$2.13
Volume 24 ore:
1.39M
Relative Volume:
0.36
Capitalizzazione di mercato:
$208.90M
Reddito:
-
Utile/perdita netta:
$-67.68M
Rapporto P/E:
-1.3072
EPS:
-1.66
Flusso di cassa netto:
$-54.24M
1 W Prestazione:
-0.91%
1M Prestazione:
-12.50%
6M Prestazione:
+43.71%
1 anno Prestazione:
-6.47%
Intervallo 1D:
$2.09
$2.19
Intervallo di 1 settimana:
$2.00
$2.275
Portata 52W:
$0.9857
$3.67
Cabaletta Bio Inc Stock (CABA) Company Profile
Nome
Cabaletta Bio Inc
Settore
Industria
Telefono
(267) 759-3100
Indirizzo
2929 ARCH STREET, PHILADELPHIA, PA
Confronta CABA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CABA
Cabaletta Bio Inc
|
2.17 | 206.01M | 0 | -67.68M | -54.24M | -1.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.68 | 122.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
801.01 | 85.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.40 | 55.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
795.57 | 50.67B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
170.27 | 37.54B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cabaletta Bio Inc Stock (CABA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-10 | Ripresa | Jefferies | Buy |
| 2024-12-20 | Downgrade | Evercore ISI | Outperform → In-line |
| 2024-12-19 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-10-10 | Iniziato | UBS | Buy |
| 2024-02-05 | Iniziato | Jefferies | Buy |
| 2023-11-29 | Iniziato | William Blair | Outperform |
| 2023-10-24 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-10-19 | Iniziato | Stifel | Buy |
| 2023-09-05 | Iniziato | Citigroup | Buy |
| 2023-07-18 | Iniziato | Guggenheim | Buy |
| 2023-01-27 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-08-30 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-08 | Iniziato | Wells Fargo | Overweight |
| 2021-10-19 | Ripresa | Morgan Stanley | Overweight |
| 2021-06-30 | Iniziato | Mizuho | Buy |
| 2021-01-08 | Iniziato | Chardan Capital Markets | Buy |
| 2020-10-13 | Iniziato | H.C. Wainwright | Buy |
| 2019-11-19 | Iniziato | Cowen | Outperform |
| 2019-11-19 | Iniziato | Evercore ISI | Outperform |
| 2019-11-19 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Cabaletta Bio Inc Borsa (CABA) Ultime notizie
Is Cabaletta Bio Inc. stock a top momentum playJuly 2025 Rallies & Risk Controlled Stock Alerts - ulpravda.ru
Aug Intraday: How sustainable is Cabaletta Bio Inc. stock dividend payoutTrade Volume Report & Weekly Breakout Stock Alerts - ulpravda.ru
Is Cabaletta Bio Inc a good long term investmentPrice Volatility Patterns & Free High Profit Capital Plays - earlytimes.in
Cabaletta Bio slides on proposed securities offering - MSN
Cabaletta Bio to Present at Guggenheim’s SMID Cap Biotech Conference - MSN
Cabaletta Bio, Inc. (NASDAQ:CABA) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Smart Money: Is Cabaletta Bio Inc stock a top momentum playMarket Trend Summary & Technical Buy Zone Confirmations - moha.gov.vn
Cabaletta Bio Inc. (CABA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Is Cabaletta Bio Inc. stock gaining market shareLong-Term Investment Plans & Small Budget Capital Growth - Bollywood Helpline
Unraveling Cabaletta Bio Inc.’s Recent Market Moves - StocksToTrade
Bull Bear: Will CHEF stock reach Wall Street targetsWeekly Stock Report & Daily Market Momentum Tracking - moha.gov.vn
Cabaletta Bio, Inc.(NasdaqGS: CABA) added to NASDAQ Biotechnology Index - marketscreener.com
History Review: Is Cabaletta Bio Inc. stock gaining market shareMarket Volume Summary & Daily Technical Forecast Reports - Улправда
Update Report: Is Cabaletta Bio Inc. stock gaining market shareProfit Target & Stepwise Trade Signal Guides - ulpravda.ru
Why Cabaletta Bio Inc. stock remains on watchlistsJuly 2025 Institutional & Weekly High Conviction Trade Ideas - ulpravda.ru
Sentiment Watch: Will Cabaletta Bio Inc. stock recover faster than marketChart Signals & Weekly Chart Analysis and Trade Guides - ulpravda.ru
Will Cabaletta Bio Inc. stock continue upward momentumMarket Rally & Capital Efficiency Focused Ideas - Улправда
Will Cabaletta Bio Inc. stock split again soonQuarterly Investment Review & AI Based Buy and Sell Signals - DonanımHaber
Can Cabaletta Bio Inc. stock deliver surprise earnings beatMarket Sentiment Review & Entry and Exit Point Strategies - DonanımHaber
How Cabaletta Bio Inc. stock benefits from global expansionCPI Data & Expert Curated Trade Setups - bolumsonucanavari.com
Cabaletta Bio Reports Positive Rese-cel Data Across Myositis, SSc, and SLE Trials - MSN
Profit Review: Will Cabaletta Bio Inc. stock recover faster than marketRisk Management & Long Hold Capital Preservation Plans - Улправда
Wells Fargo Downgrades Cabaletta Bio (CABA) - MSN
Is Cabaletta Bio (NASDAQ:CABA) In A Good Position To Invest In Growth? - Yahoo Finance
Cabaletta Bio (CABA) price target increased by 15.31% to 14.41 - MSN
Cabaletta Bio, Inc. $CABA Shares Acquired by Bain Capital Life Sciences Investors LLC - MarketBeat
Cabaletta Bio’s RESET-MG Study: A Potential Game-Changer for Myasthenia Gravis Treatment - MSN
CABA Receives FDA Orphan Status for Myasthenia Gravis Treatment - GuruFocus
Cabaletta Bio, Inc. (NASDAQ:CABA) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Weekly Earnings: Will Cabaletta Bio Inc stock recover faster than marketMarket Sentiment Report & Technical Pattern Based Buy Signals - moha.gov.vn
Cabaletta Bio (CABA) Price Target Increased by 15.31% to 14.41 - Nasdaq
Cabaletta Bio (CABA) Stock Analysis Report | Financials & Insights - Benzinga
Evercore Healthcare Conference - marketscreener.com
Is Cabaletta Bio Inc stock gaining market shareWeekly Trading Summary & Low Risk High Win Rate Picks - BỘ NỘI VỤ
Cabaletta Bio Prices Public Offering to Raise $100 Million - MSN
Cabaletta Bio Advances Rese-cel Pipeline as BLA Submission for Myositis Nears - MSN
Form 8-KCurrent report - ADVFN
Jefferies Financial Group Inc. Takes $3.04 Million Position in Cabaletta Bio, Inc. $CABA - MarketBeat
Cabaletta Bio to Present at Key Global Healthcare and Immunology Conferences - MSN
How supply chain issues affect Cabaletta Bio Inc. stock2025 Winners & Losers & Comprehensive Market Scan Insights - newser.com
Can Cabaletta Bio Inc. stock maintain operating margins2025 Market Overview & Free Real-Time Volume Trigger Notifications - newser.com
Will Cabaletta Bio Inc. stock outperform Nasdaq indexQuarterly Profit Review & High Accuracy Buy Signal Tips - newser.com
How Cabaletta Bio Inc. stock reacts to oil pricesJuly 2025 Momentum & Safe Capital Growth Trade Ideas - newser.com
How Cabaletta Bio Inc. stock performs in rising dollar environmentTrade Risk Assessment & Weekly High Momentum Picks - newser.com
CABALETTA BIO INC (CABA.MX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Why Cabaletta Bio Inc. stock could rally in 2025Bond Market & AI Based Buy/Sell Signal Reports - newser.com
Cabaletta Bio’s Bold Autoimmune Push Raises Big Questions About the Future of CAR T - MyChesCo
Tools to assess Cabaletta Bio Inc.’s risk profileJuly 2025 WrapUp & Precise Entry and Exit Recommendations - newser.com
Is Cabaletta Bio Inc. stock attractive for ETFsLong Setup & Weekly Return Optimization Plans - newser.com
Will Cabaletta Bio Inc. see short term momentumLong Setup & Real-Time Stock Entry Alerts - newser.com
Cabaletta Bio Inc Azioni (CABA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.80%
4.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):